An in vitro feasibility study of 355 nm laser atherectomy for the treatment of peripheral atherosclerotic lesions
Hui Wang,Hui Zuo,Dikang Pan,Yihui Cao,Yiqun Zhang,Duan Liu,Lianrui Guo,Jianming Guo
DOI: https://doi.org/10.1002/jbio.202400110
IF: 3.3899
2024-05-15
Journal of Biophotonics
Abstract:This study employed a novel 355 nm laser, using porcine aortas and bovine tendons to simulate arterial vessels and fibrous tissue structures, respectively. This demonstrated the safety and effectiveness of the device. Subsequently, we conducted experiments on human ex vivo arterial plaques. The results indicated that the device is effective in treating chronic occlusions, in‐stent restenosis, and mature thrombotic lesions. In this study, we utilized a novel 355 nm laser to ablate porcine aortas in the presence of physiological saline and contrast agent. Subsequently, we investigated the shape and depth of the resulting injuries. After ablating bovine tendons and aortas with the laser, we analyzed the size and quantity of particles postablation. Finally, we conducted ablation experiments using human ex vivo plaques. The analysis revealed minimal damage to porcine aortas within 2 s of exposure to the 355 nm laser. The degree of injury in the presence of contrast agent was higher than that in the presence of physiological saline but significantly lower than the damage caused by 308 nm laser. Regardless of whether it was bovine tendon or porcine aorta tissue, the proportion of particles <25 μm postlaser ablation exceeded 99%. Lastly, the 355 nm laser successfully opened three types of plaques: chronically occluded, stent restenosis, and stale thrombosis.
optics,biochemical research methods,biophysics